Careers  |  Sign In  |  Register

Latest in Oncology

Ragini Kudchadkar, MD, associate professor in the Department of Hematology and Medical Oncology, and associate director of the Hematology and Medical Oncology Fellowship Program - Clinical/Service at Emory University School of Medicine, Winship Cancer Institute, discusses how ocular melanoma and cutaneous...
In this interview, Ragini Kudchadkar, MD, associate professor in the Department of Hematology and Medical Oncology, and associate director of the Hematology and Medical Oncology Fellowship Program - Clinical/Service at Emory University School of Medicine, Winship Cancer Institute, discussed the prognosis...
By composing a systematic review of randomized clinical trials of patients with advanced melanoma, researchers were able to demonstrate that the risk for immune-related adverse effects (irAEs) is directly correlated with immune checkpoint inhibitor type. The meta-analysis, put together by Chin Yuang...